TAMMY RUSSO: Open Payments
NPI 1093976003 · NISKAYUNA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$253,252 in 394 payments from 13 companies in 2025. Trend: 2023 $96,702 · 2024 $145,855 · 2025 $253,252
Speaker / faculty: $165,461Travel & lodging: $54,006Consulting: $12,480Honoraria: $10,813Food & beverage: $10,320Education: $172
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 173 | $136,200 |
| Alkermes, Inc. | 73 | $56,117 |
| ABBVIE INC. | 49 | $24,908 |
| Teva Pharmaceuticals USA, Inc. | 27 | $14,839 |
| Axsome Therapeutics, Inc. | 21 | $12,419 |
| E.R. Squibb & Sons, L.L.C. | 9 | $7,771 |
| Janssen Pharmaceuticals, Inc | 18 | $421 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $135 |
| HARMONY BIOSCIENCES LLC | 3 | $121 |
| Neurocrine BioSciences, Inc. | 5 | $108 |
Products named: CAPLYTA, LYBALVI, VRAYLAR, AUSTEDO XR, Auvelity, COBENFY, INVEGA SUSTENNA, SPRAVATO.
Industry payments across NY — which companies pay providers there.
